Publicaciones (336) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A journey through the history of PEGylated drug delivery nanocarriers

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2026-2031

  2. A translational framework to DELIVER nanomedicines to the clinic

    Nature Nanotechnology

  3. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1

  4. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)

    npj Vaccines

  5. Controlling the protein corona of polymeric nanocapsules: effect of polymer shell on protein adsorption

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 918-933

  6. Editorial note

    Drug Delivery and Translational Research

  7. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights

    Nano Research, Vol. 17, Núm. 10, pp. 9111-9125

  8. Fifty years of sciences with Patrick Couvreur: A tribute to Professor Patrick Couvreur: a creative and visionary scientist in the field of nanomedicine

    Drug Delivery and Translational Research

  9. Formulation of protein-loaded nanoparticles via freeze-drying

    Drug Delivery and Translational Research

  10. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

    Emerging Microbes and Infections, Vol. 13, Núm. 1

  11. Integrating bioprinting, cell therapies and drug delivery towards in vivo regeneration of cartilage, bone and osteochondral tissue

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 858-894

  12. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity

    Journal of Controlled Release, Vol. 372, pp. 295-303

  13. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

    npj Vaccines, Vol. 9, Núm. 1

  14. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2046-2061

  15. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors

    Journal of Controlled Release, Vol. 373, pp. 277-292

  16. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals

    Advanced Materials, Vol. 36, Núm. 14

  17. Polyelectrolyte complexes based on a novel and sustainable hemicellulose-rich lignosulphonate for drug delivery applications

    Drug Delivery and Translational Research

  18. Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapies

    Drug Delivery and Translational Research, Vol. 14, Núm. 2, pp. 455-473